Free, Captisol-enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma . Spectrum filed a New Drug Application for approval of CE-Melphalan in December 2014 and expects a decision from the Food and Drug Administration by late 2015.
http://ift.tt/1CkI03r
http://ift.tt/1CkI03r
No comments:
Post a Comment